GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ceapro Inc (TSXV:CZO) » Definitions » E10

Ceapro (TSXV:CZO) E10 : C$0.03 (As of Dec. 2023)


View and export this data going back to 1992. Start your Free Trial

What is Ceapro E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ceapro's adjusted earnings per share data for the three months ended in Dec. 2023 was C$-0.030. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is C$0.03 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was 14.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Ceapro was 58.00% per year. The lowest was 14.50% per year. And the median was 36.25% per year.

As of today (2024-05-24), Ceapro's current stock price is C$0.27. Ceapro's E10 for the quarter that ended in Dec. 2023 was C$0.03. Ceapro's Shiller PE Ratio of today is 9.00.

During the past 13 years, the highest Shiller PE Ratio of Ceapro was 228.00. The lowest was 5.33. And the median was 20.50.


Ceapro E10 Historical Data

The historical data trend for Ceapro's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ceapro E10 Chart

Ceapro Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.02 0.03 - 0.03

Ceapro Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.03 0.03 0.03 0.03

Competitive Comparison of Ceapro's E10

For the Biotechnology subindustry, Ceapro's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ceapro's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ceapro's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ceapro's Shiller PE Ratio falls into.



Ceapro E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ceapro's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.03/125.0724*125.0724
=-0.030

Current CPI (Dec. 2023) = 125.0724.

Ceapro Quarterly Data

per share eps CPI Adj_EPS
201403 0.003 98.604 0.004
201406 0.010 99.473 0.013
201409 0.010 99.394 0.013
201412 0.010 98.367 0.013
201503 -0.003 99.789 -0.004
201506 0.010 100.500 0.012
201509 0.020 100.421 0.025
201512 0.060 99.947 0.075
201603 0.020 101.054 0.025
201606 0.020 102.002 0.025
201609 0.010 101.765 0.012
201612 0.000 101.449 0.000
201703 0.000 102.634 0.000
201706 0.005 103.029 0.006
201709 0.004 103.345 0.005
201712 -0.020 103.345 -0.024
201803 -0.004 105.004 -0.005
201806 -0.002 105.557 -0.002
201809 -0.004 105.636 -0.005
201812 0.006 105.399 0.007
201903 -0.010 106.979 -0.012
201906 -0.010 107.690 -0.012
201909 -0.001 107.611 -0.001
201912 0.010 107.769 0.012
202003 0.010 107.927 0.012
202006 0.010 108.401 0.012
202009 0.002 108.164 0.002
202012 -0.010 108.559 -0.012
202103 0.010 110.298 0.011
202106 0.010 111.720 0.011
202109 0.010 112.905 0.011
202112 0.010 113.774 0.011
202203 0.020 117.646 0.021
202206 0.020 120.806 0.021
202209 0.010 120.648 0.010
202212 0.000 120.964 0.000
202303 -0.005 122.702 -0.005
202306 -0.010 124.203 -0.010
202309 -0.010 125.230 -0.010
202312 -0.030 125.072 -0.030

Add all the adjusted EPS together and divide 10 will get our e10.


Ceapro  (TSXV:CZO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Ceapro's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=0.27/0.03
=9.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Ceapro was 228.00. The lowest was 5.33. And the median was 20.50.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Ceapro E10 Related Terms

Thank you for viewing the detailed overview of Ceapro's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Ceapro (TSXV:CZO) Business Description

Traded in Other Exchanges
Address
7824-51 Avenue NW, Edmonton, AB, CAN, T6E 6W2
Ceapro Inc is engaged in the development and marketing of various health and wellness products and technology relating to plant extracts. Its operating segment is the active ingredient product technology industry which involves the development of proprietary extraction technologies and the application of these technologies to the production and development and commercialization of active ingredients derived from oats and other renewable plant resources for healthcare and cosmetic industries. Active ingredients produced include oat beta glucan and avenanthramides. The group derives revenue from the U.S., Germany, China, Canada and other countries, of which prime revenue is generated from the U.S.

Ceapro (TSXV:CZO) Headlines

No Headlines